WO1990005183A1
(fr)
|
1988-10-31 |
1990-05-17 |
Immunex Corporation |
Recepteurs d'interleukine-4
|
US5714465A
(en)
|
1989-05-19 |
1998-02-03 |
Amgen Inc. |
Method of inhibiting tumor cell dissemination with a metalloproteinase inhibitor
|
US7144731B2
(en)
|
1989-10-16 |
2006-12-05 |
Amgen Inc. |
SCF antibody compositions and methods of using the same
|
US5574138A
(en)
|
1993-03-08 |
1996-11-12 |
Immunex Corporation |
Epithelium-derived T-cell factor
|
US7211259B1
(en)
|
1993-05-07 |
2007-05-01 |
Immunex Corporation |
4-1BB polypeptides and DNA encoding 4-1BB polypeptides
|
US7138500B1
(en)
|
1993-05-07 |
2006-11-21 |
Immunex Corporation |
Antibodies to human 4-1BB
|
US7045128B2
(en)
|
1993-05-24 |
2006-05-16 |
Immunex Corporation |
Antibodies against flt3-ligand
|
US6630143B1
(en)
|
1993-05-24 |
2003-10-07 |
Immunex Corporation |
Antibodies against flt3 ligand
|
US6303769B1
(en)
|
1994-07-08 |
2001-10-16 |
Immunex Corporation |
Lerk-5 dna
|
US5885574A
(en)
|
1994-07-26 |
1999-03-23 |
Amgen Inc. |
Antibodies which activate an erythropoietin receptor
|
US5919905A
(en)
|
1994-10-05 |
1999-07-06 |
Immunex Corporation |
Cytokine designated LERK-6
|
US6406901B1
(en)
|
1995-06-08 |
2002-06-18 |
Immunex Corporation |
TNF-a converting enzyme
|
EP0938499A1
(fr)
|
1996-07-19 |
1999-09-01 |
Amgen Inc. |
Analogues de proteines cationiques
|
AU713473B2
(en)
|
1996-12-23 |
1999-12-02 |
Immunex Corporation |
Receptor activator of NF-kappa B, receptor is member of TNF receptor superfamily
|
US5741772A
(en)
|
1997-02-03 |
1998-04-21 |
Amgen Inc. |
Neurotrophic factor NNT-1
|
RO128635A2
(ro)
|
1997-04-16 |
2013-07-30 |
Amgen Inc. |
Anticorp sau fragment al acestuia care se leagă la opgbp şi utilizarea acestuia, utilizarea unei forme solubile de odar, şi metodă de identificare a unui compus care descreşte activitatea opgbp
|
US6316408B1
(en)
|
1997-04-16 |
2001-11-13 |
Amgen Inc. |
Methods of use for osetoprotegerin binding protein receptors
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
US20020173629A1
(en)
|
1997-05-05 |
2002-11-21 |
Aya Jakobovits |
Human monoclonal antibodies to epidermal growth factor receptor
|
ATE305510T1
(de)
|
1997-12-17 |
2005-10-15 |
Immunex Corp |
Zelloberflächenglycoproteinen zusammenhang mit menschlicher b zell lymphomen - ulbp, dns und polypeptiden
|
AU755391B2
(en)
|
1997-12-23 |
2002-12-12 |
Immunex Corporation |
SIGIRR DNA and polypeptides
|
AU1682699A
(en)
|
1997-12-25 |
1999-07-19 |
Japan Tobacco Inc. |
Monoclonal antibody against connective tissue growth factor and medicinal uses thereof
|
WO1999037773A1
(fr)
|
1998-01-23 |
1999-07-29 |
Immunex Corporation |
ADN ET POLYPEPTIDES AcPL
|
AU776825B2
(en)
|
1998-08-07 |
2004-09-23 |
Immunex Corporation |
Molecules designated LDCAM
|
DE69939982D1
(de)
|
1998-08-07 |
2009-01-08 |
Immunex Corp |
B7l-1 moleküle
|
DE69936105T3
(de)
|
1998-11-13 |
2017-07-27 |
Immunex Corporation |
Menschliche tslp nukleinsäuren und polypeptide
|
US7109003B2
(en)
|
1998-12-23 |
2006-09-19 |
Abgenix, Inc. |
Methods for expressing and recovering human monoclonal antibodies to CTLA-4
|
US6682736B1
(en)
|
1998-12-23 |
2004-01-27 |
Abgenix, Inc. |
Human monoclonal antibodies to CTLA-4
|
US7435796B1
(en)
|
1999-02-03 |
2008-10-14 |
Amgen Inc. |
Antibodies which bind B7RP1
|
US7459540B1
(en)
|
1999-09-07 |
2008-12-02 |
Amgen Inc. |
Fibroblast growth factor-like polypeptides
|
JP2001206899A
(ja)
|
1999-11-18 |
2001-07-31 |
Japan Tobacco Inc |
TGF−βII型受容体に対するヒトモノクローナル抗体及びその医薬用途
|
US20030103978A1
(en)
|
2000-02-23 |
2003-06-05 |
Amgen Inc. |
Selective binding agents of osteoprotegerin binding protein
|
DE16192152T1
(de)
|
2000-05-26 |
2020-08-06 |
Immunex Corporation |
Verwendung von interleukin-4 rezeptor (il-4r) antikörpern und zusammensetzungen davon
|
ES2327102T3
(es)
|
2000-09-05 |
2009-10-26 |
Amgen Inc. |
Moleculas analogas al receptor de tnf y usos de las mismas.
|
WO2002053596A2
(fr)
|
2001-01-05 |
2002-07-11 |
Pfizer Inc. |
Anticorps anti-recepteur du facteur de croissance insulinoide i
|
AU2002356511A1
(en)
|
2001-07-30 |
2003-04-01 |
Immunex Corporation |
T. reesei phytase enyzmes, polynucleides encoding the enzymes, vectors and host cells thereof, and methods of using
|
US7084257B2
(en)
|
2001-10-05 |
2006-08-01 |
Amgen Inc. |
Fully human antibody Fab fragments with human interferon-gamma neutralizing activity
|
US7658924B2
(en)
|
2001-10-11 |
2010-02-09 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
US7521053B2
(en)
|
2001-10-11 |
2009-04-21 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
EP3184539A3
(fr)
|
2001-10-23 |
2017-09-13 |
PSMA Development Company L.L.C. |
Anticorps contre le psma
|
AR039067A1
(es)
|
2001-11-09 |
2005-02-09 |
Pfizer Prod Inc |
Anticuerpos para cd40
|
CA2467597A1
(fr)
|
2001-12-03 |
2003-06-12 |
Abgenix, Inc. |
Anticorps anti-cd45rb s'utilisant dans le traitement de maladies auto-immunes et de rejet de greffon
|
EP1461082A4
(fr)
|
2001-12-03 |
2006-06-28 |
Abgenix Inc |
Anticorps contre l'antigene tumoral de l'anhydrase carbonique ix (ca ix)
|
US20040093621A1
(en)
*
|
2001-12-25 |
2004-05-13 |
Kyowa Hakko Kogyo Co., Ltd |
Antibody composition which specifically binds to CD20
|
JP2005516965A
(ja)
|
2001-12-28 |
2005-06-09 |
アブジェニックス・インコーポレーテッド |
抗muc18抗体を使用する方法
|
EP1467757B1
(fr)
|
2001-12-28 |
2008-05-07 |
Amgen Fremont Inc. |
Utilisation d'anticorps diriges contre l'antigene muc18
|
ATE364618T1
(de)
|
2001-12-28 |
2007-07-15 |
Amgen Fremont Inc |
Antikörper gegen das muc18-antigen
|
US7135174B2
(en)
|
2002-01-07 |
2006-11-14 |
Amgen Fremont, Inc. |
Antibodies directed to PDGFD and uses thereof
|
ATE435239T1
(de)
|
2002-03-29 |
2009-07-15 |
Schering Corp |
Menschliche monoklonale antikörper gegen interleukin-5 sowie diese umfassende verfahren und zusammensetzungen
|
EP1494714A4
(fr)
|
2002-04-05 |
2008-03-05 |
Amgen Inc |
Anticorps humain neutralisant anti opgl utilises en tant qu'inhibiteurs de chemin d'opgl
|
UA87979C2
(ru)
|
2002-08-19 |
2009-09-10 |
Астразенека Аб |
Человеческое моноклональное антитело, которое нейтрализует моноцитарный хемоатрактантный белок (мср-1)
|
EA018072B1
(ru)
|
2002-09-06 |
2013-05-30 |
Амджен Инк. |
Антитело к рецептору интерлейкина-1 типа 1 (il-1r1) и его применение
|
AU2003285874A1
(en)
|
2002-10-16 |
2004-05-04 |
Amgen Inc. |
HUMAN ANTI-IFN-Gamma NEUTRALIZING ANTIBODIES AS SELECTIVE IFN-Gamma PATHWAY INHIBITORS
|
RU2377253C2
(ru)
|
2002-12-02 |
2009-12-27 |
Амген Фремонт,Инк. |
Антитела, специфичные к фактору некроза опухолей, и их применение
|
KR20130065723A
(ko)
|
2003-06-27 |
2013-06-19 |
암젠 프레몬트 인코포레이티드 |
상피 성장 인자 수용체의 결실 돌연변이체 지향 항체 및 그 용도
|
SI1648509T1
(sl)
|
2003-07-15 |
2012-12-31 |
Amgen Inc. |
Humana protitelesa, ki nevtralizirajo anti-ngf, kot selektivni inhibitorji poti nfg
|
JP2007500132A
(ja)
|
2003-07-25 |
2007-01-11 |
アムジェン インコーポレイテッド |
Ldcamのアンタゴニストおよびアゴニスト、並びにその使用法
|
HN2004000285A
(es)
|
2003-08-04 |
2006-04-27 |
Pfizer Prod Inc |
ANTICUERPOS DIRIGIDOS A c-MET
|
US7318925B2
(en)
|
2003-08-08 |
2008-01-15 |
Amgen Fremont, Inc. |
Methods of use for antibodies against parathyroid hormone
|
CN1838968A
(zh)
|
2003-08-08 |
2006-09-27 |
艾伯吉尼斯公司 |
针对甲状旁腺激素(pth)之抗体和其用途
|
AR045563A1
(es)
|
2003-09-10 |
2005-11-02 |
Warner Lambert Co |
Anticuerpos dirigidos a m-csf
|
ATE548388T1
(de)
|
2003-11-07 |
2012-03-15 |
Immunex Corp |
An den interleukin-4-rezeptor bindende antikörper
|
US7371381B2
(en)
|
2003-12-12 |
2008-05-13 |
Amgen Inc. |
Anti-galanin antibodies and uses thereof
|
DK2177537T3
(da)
|
2004-01-09 |
2011-12-12 |
Pfizer |
Antistoffer til MAdCAM
|
WO2005117970A2
(fr)
|
2004-04-23 |
2005-12-15 |
Amgen, Inc. |
Anticorps de l'angiogenese inhibant des domaines de cd148
|
US20050287140A1
(en)
|
2004-04-23 |
2005-12-29 |
Amgen Inc. |
Antibodies to angiogenesis inhibiting domains of CD148
|
ES2414460T3
(es)
|
2004-08-04 |
2013-07-19 |
Amgen Inc. |
Anticuerpos para Dkk-1
|
US7423128B2
(en)
|
2004-11-03 |
2008-09-09 |
Amgen Fremont Inc. |
Anti-properdin antibodies, and methods for making and using same
|
DE602005025525D1
(de)
|
2004-11-17 |
2011-02-03 |
Amgen Inc |
Vollständige humane monoklonale antikörper gegen il-13
|
MY146381A
(en)
|
2004-12-22 |
2012-08-15 |
Amgen Inc |
Compositions and methods relating relating to anti-igf-1 receptor antibodies
|
US7906625B2
(en)
|
2005-01-24 |
2011-03-15 |
Amgen Inc. |
Humanized anti-amyloid antibody
|
CA2590164A1
(fr)
|
2005-01-26 |
2006-08-03 |
Amgen Fremont Inc. |
Anticorps diriges contre interleukine-1 beta
|
WO2006104677A2
(fr)
|
2005-03-24 |
2006-10-05 |
Millennium Pharmaceuticals, Inc. |
Anticorps se liant a ov064 et leurs methodes d'utilisation
|
US7807159B2
(en)
|
2005-04-25 |
2010-10-05 |
Amgen Fremont Inc. |
Antibodies to myostatin
|
US7592429B2
(en)
|
2005-05-03 |
2009-09-22 |
Ucb Sa |
Sclerostin-binding antibody
|
NO345593B1
(no)
|
2005-07-18 |
2021-05-03 |
Amgen Inc |
Humane anti-B7RP1 nøytraliserende antistoffer
|
PE20071101A1
(es)
|
2005-08-31 |
2007-12-21 |
Amgen Inc |
Polipeptidos y anticuerpos
|
PT2447283E
(pt)
|
2005-09-07 |
2015-10-08 |
Pfizer |
Anticorpos monoclonais humanos para cinase-1 tipo recetor de activina (alk-1)
|
RS52357B
(en)
|
2005-12-13 |
2012-12-31 |
Medimmune Limited |
BINDING PROTEINS SPECIFIC TO INSULIN SIMILAR GROWTH FACTORS AND THEIR USE
|
AR056857A1
(es)
|
2005-12-30 |
2007-10-24 |
U3 Pharma Ag |
Anticuerpos dirigidos hacia her-3 (receptor del factor de crecimiento epidérmico humano-3) y sus usos
|
US7888482B2
(en)
|
2006-02-10 |
2011-02-15 |
Amgen Inc. |
Antibodies that bind PAR-2
|
TWI395754B
(zh)
|
2006-04-24 |
2013-05-11 |
Amgen Inc |
人類化之c-kit抗體
|
EP2035454A2
(fr)
|
2006-05-19 |
2009-03-18 |
Amgen, Inc. |
Anticorps au coronavirus sras
|
CL2007002567A1
(es)
|
2006-09-08 |
2008-02-01 |
Amgen Inc |
Proteinas aisladas de enlace a activina a humana.
|
CL2007002668A1
(es)
|
2006-09-20 |
2008-05-09 |
Amgen Inc |
Proteina de union a antigeno que se une al receptor de glucagon humano; acido nucleico que la codifica; metodo de produccion; composicion farmaceutica que la comprende; y su uso para tratar o prevenir la diabetes tipo 2.
|
US7767206B2
(en)
|
2006-10-02 |
2010-08-03 |
Amgen Inc. |
Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
|
UY30994A1
(es)
|
2007-04-02 |
2008-11-28 |
Amgen Fremont Inc |
Anticuerpos anti-ige
|
CL2008001887A1
(es)
|
2007-06-29 |
2008-10-03 |
Amgen Inc |
Proteinas de union a antigeno que se unen al receptor activado por proteasas 2 (par-2); acido nucleico que las codifica; vector y celula huesped; metodo de produccion; y composicion que las comprende.
|
CL2008002153A1
(es)
|
2007-07-24 |
2009-06-05 |
Amgen Inc |
Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r.
|
RS56743B1
(sr)
|
2007-08-21 |
2018-03-30 |
Amgen Inc |
Humani c-fms antigen vezujući proteini
|
JOP20080381B1
(ar)
|
2007-08-23 |
2023-03-28 |
Amgen Inc |
بروتينات مرتبطة بمولدات مضادات تتفاعل مع بروبروتين كونفيرتاز سيتيليزين ككسين من النوع 9 (pcsk9)
|
US7982016B2
(en)
|
2007-09-10 |
2011-07-19 |
Amgen Inc. |
Antigen binding proteins capable of binding thymic stromal lymphopoietin
|
WO2009085200A2
(fr)
|
2007-12-21 |
2009-07-09 |
Amgen Inc. |
Anticorps anti-amyloïde et utilisations de ceux-ci
|
JO2913B1
(en)
|
2008-02-20 |
2015-09-15 |
امجين إنك, |
Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
|
MX2010011717A
(es)
|
2008-05-01 |
2010-11-30 |
Amgen Inc |
Anticuerpos anti-hepcidina y metodos de uso.
|
MX2011009897A
(es)
|
2009-03-20 |
2011-12-08 |
Amgen Inc |
Anticuerpo de antagonista especifico de heterodimero alfa-4-beta-7.
|
UA109888C2
(uk)
|
2009-12-07 |
2015-10-26 |
|
ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ
|
CN103320388B
(zh)
*
|
2012-03-20 |
2015-10-28 |
无锡药明康德生物技术股份有限公司 |
提高抗体表达量和改良糖基化水平的细胞培养方法
|
EP3024922A4
(fr)
*
|
2013-07-23 |
2017-03-29 |
Biocon Limited |
Procédés pour contrôler les niveaux de fucosylation dans des protéines
|
SI3110961T1
(sl)
*
|
2014-02-27 |
2020-03-31 |
F. Hoffmann-La Roche Ag |
Modulacija rasti celic in glikozilacije pri rekombinantni proizvodnji glikoproteina
|
EP3227454B1
(fr)
*
|
2014-12-01 |
2020-01-29 |
Amgen Inc. |
Procédé de manipulation du taux de contenu de glycane d'une glycoprotéine
|
MX2018004831A
(es)
*
|
2015-11-02 |
2018-08-01 |
Genentech Inc |
Metodos para confeccionar formas fucosiladas y afucosiladas de una proteina.
|
CA3002120A1
(fr)
*
|
2015-11-11 |
2017-05-18 |
Ares Trading S.A. |
Procedes de modulation de profils de production de proteines recombinees
|
AU2017206012A1
(en)
*
|
2016-01-06 |
2018-07-26 |
Outlook Therapeutics, Inc. |
Reduction of high molecular weight species, acidic charge species, and fragments in a monoclonal antibody composition
|
CN109153716A
(zh)
*
|
2016-01-06 |
2019-01-04 |
安口生物公司 |
调节单克隆抗体组合物中的非岩藻糖基化物类
|
WO2017134667A1
(fr)
*
|
2016-02-02 |
2017-08-10 |
Insight Biopharmaceuticals Ltd. |
Procédés de génération d'anticorps
|